Ruth Ruscheweyh

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 120 publications

External Dynamic Visual Noise Matched to the Appearance of Visual Snow Fails to Reproduce Key Perceptual Properties of the Phenomenon.

External Dynamic Visual Noise Matched to the Appearance of Visual Snow Fails to Reproduce Key Perceptual Properties of the Phenomenon.

Journal: Investigative ophthalmology & visual science

Published: August 13, 2026

Tear Fluid Calcitonin Gene-Related Peptide Levels Are Elevated in Glycerol Trinitrate-Induced Cluster Headache Attacks: Results From an Exploratory Study.

Tear Fluid Calcitonin Gene-Related Peptide Levels Are Elevated in Glycerol Trinitrate-Induced Cluster Headache Attacks: Results From an Exploratory Study.

Journal: European journal of neurology

Published: July 06, 2026

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Journal: Cephalalgia : an international journal of headache

Published: June 19, 2026

Weekend headache in migraine - fact or fiction? An observational study from DMKG-app data.

Weekend headache in migraine - fact or fiction? An observational study from DMKG-app data.

Journal: Cephalalgia : an international journal of headache

Published: June 18, 2026

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Journal: Neurology

Published: May 27, 2026

Tear fluid Calcitonin gene-related peptide in patients with idiopathic intracranial hypertension headache - a prospective case-control study.

Tear fluid Calcitonin gene-related peptide in patients with idiopathic intracranial hypertension headache - a prospective case-control study.

Journal: The journal of headache and pain

Published: May 25, 2026

Headache after vaccination - always harmless?

Headache after vaccination - always harmless?

Journal: MMW Fortschritte der Medizin

Published: March 20, 2026

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Journal: Neurology

Published: January 28, 2026

Tear fluid calcitonin gene-related peptide (CGRP) is elevated during spontaneous migraine attacks - results from a pilot study.

Tear fluid calcitonin gene-related peptide (CGRP) is elevated during spontaneous migraine attacks - results from a pilot study.

Journal: The journal of headache and pain

Published: November 26, 2025

Risk factors associated to disability in primary headaches: a systematic review to inform future iterations of the Global Burden of Disease Study.

Risk factors associated to disability in primary headaches: a systematic review to inform future iterations of the Global Burden of Disease Study.

Journal: The journal of headache and pain

Published: October 23, 2025

Somatosensory perception in Visual Snow Syndrome: a comparison to age-, sex- and migraine-matched controls using Quantitative Sensory Testing - no evidence of altered somatosensory thresholds.

Somatosensory perception in Visual Snow Syndrome: a comparison to age-, sex- and migraine-matched controls using Quantitative Sensory Testing - no evidence of altered somatosensory thresholds.

Journal: The journal of headache and pain

Published: August 02, 2025

Migraine patients treated with CGRP(R) antibodies : Are they different from patients treated with nonspecific oral prophylaxis? Analysis from the DMKG headache registry

Migraine patients treated with CGRP(R) antibodies : Are they different from patients treated with nonspecific oral prophylaxis? Analysis from the DMKG headache registry

Journal: Schmerz (Berlin, Germany)

Published: July 02, 2025

Showing 1-12 of 120

Last Updated: 09/26/2026